{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:25:15Z","timestamp":1792445115227,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["109TMU-SHH-15"],"award-info":[{"award-number":["109TMU-SHH-15"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 108-2314-B-384-004"],"award-info":[{"award-number":["MOST 108-2314-B-384-004"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00428-022-03342-3","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T05:02:36Z","timestamp":1654232556000},"page":"283-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Bo-Jung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Tsu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Kuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Chu","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-525X","authenticated-orcid":false,"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"3342_CR1","unstructured":"McKenna RW, Kyle RA, Kuehl WM, Harris NL, Coupland RW, Fend F (2017) Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues revised, 4th edn. International Agency for Research on Cancer (IARC) 69372 Lyon Cedex 08, France, pp 241\u2013258"},{"issue":"12","key":"3342_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538-548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"issue":"3","key":"3342_CR3","first-page":"315","volume":"14","author":"K Wutke","year":"1981","unstructured":"Wutke K, Varbiro M, Rudiger KD, Kelenyi G (1981) Cytological and histological classification of multiple myeloma. Haematologia (Budap) 14(3):315\u2013329","journal-title":"Haematologia (Budap)"},{"issue":"2","key":"3342_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1182\/blood.V65.2.305.305","volume":"65","author":"PR Greipp","year":"1985","unstructured":"Greipp PR, Raymond NM, Kyle RA, O\u2019Fallon WM (1985) Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 65(2):305\u2013310","journal-title":"Blood"},{"issue":"3","key":"3342_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","volume":"87","author":"R Bartl","year":"1987","unstructured":"Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W (1987) Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 87(3):342\u2013355. https:\/\/doi.org\/10.1093\/ajcp\/87.3.342","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"3342_CR6","doi-asserted-by":"publisher","first-page":"e240998","DOI":"10.1136\/bcr-2020-240998","volume":"14","author":"B Ayeboa-Sallah","year":"2021","unstructured":"Ayeboa-Sallah B, Qutab S, Grace R, Sharma N (2021) Rare case of plasmablastic myeloma diagnosed on lung biopsy. BMJ Case Rep 14(3):e240998. https:\/\/doi.org\/10.1136\/bcr-2020-240998","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3342_CR7","doi-asserted-by":"publisher","first-page":"e234436","DOI":"10.1136\/bcr-2020-234436","volume":"13","author":"JA Suarez-Londono","year":"2020","unstructured":"Suarez-Londono JA, Rohatgi A, Antoine-Pepeljugoski C, Braunstein MJ (2020) Aggressive presentation of plasmablastic myeloma. BMJ Case Rep 13(4):e234436. https:\/\/doi.org\/10.1136\/bcr-2020-234436","journal-title":"BMJ Case Rep"},{"issue":"6","key":"3342_CR8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/PAS.0000000000001459","volume":"44","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jelloul F, Zhang Y, Bhavsar T, Ho C, Rao M et al (2020) Genetic basis of extramedullary plasmablastic transformation of multiple myeloma. Am J Surg Pathol 44(6):838\u2013848. https:\/\/doi.org\/10.1097\/PAS.0000000000001459","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3342_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4291\/wjgp.v8.i2.93","volume":"8","author":"S Licci","year":"2017","unstructured":"Licci S (2017) Duodenal localization of plasmablastic myeloma. World J Gastrointest Pathophysiol 8(2):93\u201395. https:\/\/doi.org\/10.4291\/wjgp.v8.i2.93","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"1","key":"3342_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/his.13196","volume":"71","author":"E Marks","year":"2017","unstructured":"Marks E, Shi Y, Wang Y (2017) CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma. Histopathology 71(1):81\u201388. https:\/\/doi.org\/10.1111\/his.13196","journal-title":"Histopathology"},{"issue":"8","key":"3342_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/apm.12411","volume":"123","author":"HE Moller","year":"2015","unstructured":"Moller HE, Preiss BS, Pedersen P, Kristensen IB, Hansen CT, Frederiksen M et al (2015) Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort. APMIS 123(8):652\u2013658. https:\/\/doi.org\/10.1111\/apm.12411","journal-title":"APMIS"},{"issue":"3","key":"3342_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/modpathol.2013.159","volume":"27","author":"JT Geyer","year":"2014","unstructured":"Geyer JT, Niesvizky R, Jayabalan DS, Mathew S, Subramaniyam S, Geyer AI et al (2014) IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol 27(3):375\u2013381. https:\/\/doi.org\/10.1038\/modpathol.2013.159","journal-title":"Mod Pathol"},{"issue":"2","key":"3342_CR13","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.clml.2013.12.003","volume":"14","author":"OL Bohn","year":"2014","unstructured":"Bohn OL, Hsu K, Hyman DM, Pignataro DS, Giralt S, Teruya-Feldstein J (2014) BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation. Clin Lymphoma Myeloma Leuk 14(2):e65-68. https:\/\/doi.org\/10.1016\/j.clml.2013.12.003","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"3342_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","volume":"128","author":"ST Chang","year":"2007","unstructured":"Chang ST, Liao YL, Lu CL, Chuang SS, Li CY (2007) Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV. Am J Clin Pathol 128(2):339\u2013344. https:\/\/doi.org\/10.1309\/27H8XJH31F3GUNAT","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"3342_CR15","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","volume":"91","author":"PR Greipp","year":"1998","unstructured":"Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA et al (1998) Plasmablastic morphology\u2013an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood 91(7):2501\u20132507","journal-title":"Blood"},{"issue":"6","key":"3342_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/modpathol.3800355","volume":"18","author":"F Vega","year":"2005","unstructured":"Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC et al (2005) Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 18(6):806\u2013815. https:\/\/doi.org\/10.1038\/modpathol.3800355","journal-title":"Mod Pathol"},{"issue":"7","key":"3342_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/his.13475","volume":"72","author":"A Sakakibara","year":"2018","unstructured":"Sakakibara A, Kohno K, Eladl AE, Klaisuwan T, Ishikawa E, Suzuki Y et al (2018) Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells. Histopathology 72(7):1156\u20131163. https:\/\/doi.org\/10.1111\/his.13475","journal-title":"Histopathology"},{"key":"3342_CR18","unstructured":"Campo E, Stein H, Harris NL (2017) Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues revised, 4th edn. International Agency for Research on Cancer (IARC) 69372 Lyon Cedex 08, France, pp 321\u2013322"},{"issue":"4","key":"3342_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413\u20131420","journal-title":"Blood"},{"issue":"7","key":"3342_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","volume":"38","author":"J Morscio","year":"2014","unstructured":"Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X et al (2014) Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 38(7):875\u2013886. https:\/\/doi.org\/10.1097\/PAS.0000000000000234","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3342_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","volume":"37","author":"D Martinez","year":"2013","unstructured":"Martinez D, Valera A, Perez NS, Sua Villegas LF, Gonzalez-Farre B, Sole C et al (2013) Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases. Am J Surg Pathol 37(2):272\u2013281. https:\/\/doi.org\/10.1097\/PAS.0b013e31826cb1d1","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"3342_CR22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","volume":"15","author":"J Teruya-Feldstein","year":"2004","unstructured":"Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673\u20131679. https:\/\/doi.org\/10.1093\/annonc\/mdh399","journal-title":"Ann Oncol"},{"issue":"6","key":"3342_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","volume":"28","author":"L Colomo","year":"2004","unstructured":"Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736\u2013747. https:\/\/doi.org\/10.1097\/01.pas.0000126781.87158.e3","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3342_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/PAP.0000000000000253","volume":"27","author":"BJ Chen","year":"2020","unstructured":"Chen BJ, Chuang SS (2020) Lymphoid neoplasms with plasmablastic differentiation: a comprehensive review and diagnostic approaches. Adv Anat Pathol 27(2):61\u201374. https:\/\/doi.org\/10.1097\/PAP.0000000000000253","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"3342_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/sj.leu.2403206","volume":"18","author":"I Simonitsch-Klupp","year":"2004","unstructured":"Simonitsch-Klupp I, Hauser I, Ott G, Drach J, Ackermann J, Kaufmann J et al (2004) Diffuse large B-cell lymphomas with plasmablastic\/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 18(1):146\u2013155. https:\/\/doi.org\/10.1038\/sj.leu.2403206","journal-title":"Leukemia"},{"issue":"3","key":"3342_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0609.1995.tb00204.x","volume":"54","author":"M Sailer","year":"1995","unstructured":"Sailer M, Vykoupil KF, Peest D, Coldewey R, Deicher H, Georgii A (1995) Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol 54(3):137\u2013146. https:\/\/doi.org\/10.1111\/j.1600-0609.1995.tb00204.x","journal-title":"Eur J Haematol"},{"issue":"4","key":"3342_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F et al (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res 2(4):247\u2013258. https:\/\/doi.org\/10.1002\/cjp2.53","journal-title":"J Pathol Clin Res"},{"issue":"10027","key":"3342_CR28","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, Perez-Gracia JL, Han JY et al (2016) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 387(10027):1540\u20131550. https:\/\/doi.org\/10.1016\/S0140-6736(15)01281-7","journal-title":"Lancet"},{"issue":"10","key":"3342_CR29","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jtho.2021.05.001","volume":"16","author":"RS Herbst","year":"2021","unstructured":"Herbst RS, Garon EB, Kim DW, Cho BC, Gervais R, Perez-Gracia JL et al (2021) Five year survival update from KEYNOTE-010: pembrolizumab versus docetaxel for previously treated, programmed death-ligand 1-positive advanced NSCLC. J Thorac Oncol 16(10):1718\u20131732. https:\/\/doi.org\/10.1016\/j.jtho.2021.05.001","journal-title":"J Thorac Oncol"},{"issue":"2","key":"3342_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/PAP.0000000000000290","volume":"28","author":"CY Liu","year":"2021","unstructured":"Liu CY, Chuang SS (2021) A simple and practical guide for triaging lymphocyte-rich effusions for ancillary studies. Adv Anat Pathol 28(2):94\u2013104. https:\/\/doi.org\/10.1097\/PAP.0000000000000290","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"3342_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.pathol.2018.03.011","volume":"50","author":"ST Chang","year":"2018","unstructured":"Chang ST, Hsieh YC, Kuo CC, Chuang SS (2018) Colonic CD30 positive plasmablastic plasmacytoma masquerading as anaplastic large cell lymphoma. Pathology 50(6):668\u2013670. https:\/\/doi.org\/10.1016\/j.pathol.2018.03.011","journal-title":"Pathology"},{"issue":"4","key":"3342_CR32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/leu.2012.336","volume":"27","author":"C Fernandez de Larrea","year":"2013","unstructured":"Fernandez de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH et al (2013) Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 27(4):780\u2013791. https:\/\/doi.org\/10.1038\/leu.2012.336","journal-title":"Leukemia"},{"issue":"11","key":"3342_CR33","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balague O, Colomo L, Martinez A, Delabie J, Taddesse-Heath L et al (2010) IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34(11):1686\u20131694. https:\/\/doi.org\/10.1097\/PAS.0b013e3181f3e29f","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"3342_CR34","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/modpathol.2010.72","volume":"23","author":"L Taddesse-Heath","year":"2010","unstructured":"Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES (2010) Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol 23(7):991\u2013999. https:\/\/doi.org\/10.1038\/modpathol.2010.72","journal-title":"Mod Pathol"},{"issue":"1","key":"3342_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/modpathol.2016.162","volume":"30","author":"S Montes-Moreno","year":"2017","unstructured":"Montes-Moreno S, Martinez-Magunacelaya N, Zecchini-Barrese T, Villambrosia SG, Linares E, Ranchal T et al (2017) Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. Mod Pathol 30(1):85\u201394. https:\/\/doi.org\/10.1038\/modpathol.2016.162","journal-title":"Mod Pathol"},{"issue":"1","key":"3342_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/2643-3230.BCD-20-0051","volume":"1","author":"Z Liu","year":"2020","unstructured":"Liu Z, Filip I, Gomez K, Engelbrecht D, Meer S, Lalloo PN et al (2020) Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. Blood Cancer Discov 1(1):112\u2013125. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0051","journal-title":"Blood Cancer Discov"},{"issue":"10","key":"3342_CR37","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","volume":"106","author":"JE Ramis-Zaldivar","year":"2021","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F et al (2021) MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica 106(10):2682\u20132693. https:\/\/doi.org\/10.3324\/haematol.2020.271957","journal-title":"Haematologica"},{"issue":"4","key":"3342_CR38","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","volume":"106","author":"J Garcia-Reyero","year":"2021","unstructured":"Garcia-Reyero J, Martinez Magunacelaya N, Gonzalez de Villambrosia S, Loghavi S, Gomez Mediavilla A, Tonda R et al (2021) Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. Haematologica 106(4):1120\u20131128. https:\/\/doi.org\/10.3324\/haematol.2020.251579","journal-title":"Haematologica"},{"issue":"8","key":"3342_CR39","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al (2007) Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 109(8):3489\u20133495. https:\/\/doi.org\/10.1182\/blood-2006-08-040410","journal-title":"Blood"},{"issue":"4","key":"3342_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1309\/BDR9-59TT-4JU6-388C","volume":"125","author":"JR Cook","year":"2006","unstructured":"Cook JR, Hsi ED, Worley S, Tubbs RR, Hussein M (2006) Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol 125(4):615\u2013624. https:\/\/doi.org\/10.1309\/BDR9-59TT-4JU6-388C","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"3342_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/his.12640","volume":"67","author":"S Loghavi","year":"2015","unstructured":"Loghavi S, Khoury JD, Medeiros LJ (2015) Epstein-Barr virus-positive plasmacytoma in immunocompetent patients. Histopathology 67(2):225\u2013234. https:\/\/doi.org\/10.1111\/his.12640","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03342-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:09:03Z","timestamp":1659341343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03342-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3342"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03342-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Internal Review Board of Chi-Mei Medical Center, Tainan, Taiwan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The consent for publication will be provided after acceptance.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}